Physician profile
Nilofar Islam
NPI 1588644074
$61,405.49
in general payments reported to CMS, 2019-2025
32 companies · $3,906 in 2025
The $3,906 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,110 · 2020: $1,371 · 2021: $9,443 · 2022: $25K · 2023: $8,456 · 2024: $12K · 2025: $3,906.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,480 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,720 · Food and Beverage: $6,265 · Travel and Lodging: $2,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,480.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,720.00 |
| Food and Beverage | $6,264.73 |
| Travel and Lodging | $2,909.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $33,449.70 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Cook Incorporated | $12,205.00 | 2022-2023 | Evolution |
| Abbott Laboratories | $9,952.82 | 2019-2025 | Aveir, Assurity, Mitraclip |
| Medtronic, INC. | $1,587.90 | 2021-2025 | Micra, Mycarelink, Omniasecure Mri Surescan |
| Cook Medical LLC | $1,347.57 | 2020-2024 | Evolution, Tornado |
| Biosense Webster, INC. | $564.01 | 2023-2025 | Carto 3, Octaray Mapping Catheter |
| Medtronic Vascular, INC. | $482.65 | 2019 | |
| Cardiva Medical, INC. | $242.15 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $216.13 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $205.03 | 2023-2025 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $143.74 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $119.36 | 2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $102.28 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $94.71 | 2023-2025 | Farxiga |
| Baxter Healthcare | $90.47 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $78.61 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Actelion Pharmaceuticals US, INC. | $71.06 | 2024-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $59.86 | 2023-2024 | Verquvo |
| Scpharmaceuticals INC. | $55.26 | 2024-2025 | |
| Novo Nordisk INC | $48.98 | 2023-2025 | Ozempic, Rybelsus |
| Terumo Medical Corporation | $36.43 | 2025 | Glidewire, Metacross Otw, Angio-Seal |
| Biotronik INC. | $34.75 | 2021-2023 | Acticor 7 Vr-T Dx |
| Alnylam Pharmaceuticals INC. | $30.85 | 2025 | Amvuttra |
| Atricure, INC. | $27.28 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.31 | 2024 | Lifevest |
| Amgen INC. | $21.78 | 2023 | Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $21.42 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $21.33 | 2024 | |
| Teleflex LLC | $21.21 | 2024 | Guideliner |
| Sanofi-Aventis U.S. LLC | $18.78 | 2024 | |
| Irhythm Technologies, INC. | $17.73 | 2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $14.33 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nilofar Islam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.